Renaissance Technologies’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.6M | Buy |
|
|||||
|
2025
Q1 | $4.54M | Buy |
|
|||||
|
2024
Q4 | $4.1M | Sell |
|
|||||
|
2024
Q3 | $4.48M | Sell |
|
|||||
|
2024
Q2 | $5.93M | Sell |
|
|||||
|
2024
Q1 | $8.08M | Sell |
|
|||||
|
2023
Q4 | $10.5M | Buy |
|
|||||
|
2023
Q3 | $1.43M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $7.12M | Buy |
|
|||||
|
2022
Q2 | $1.34M | Sell |
|
|||||
|
2022
Q1 | $4.09M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $5.87M | Sell |
|
|||||
|
2021
Q2 | $16.3M | Buy |
|
|||||
|
2021
Q1 | $686K | Sell |
|
|||||
|
2020
Q4 | $9.54M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $2.9M | Buy |
|
|||||
|
2019
Q3 | $604K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $1.66M | Sell |
|
|||||
|
2018
Q2 | $2.26M | Sell |
|
|||||
|
2018
Q1 | $3.66M | Buy |
|
|||||
|
2017
Q4 | $1.95M | Buy |
|
|||||
|
2017
Q3 | $1.19M | Sell |
|
|||||
|
2017
Q2 | $2.25M | Buy |
|
|||||
|
2017
Q1 | $1.84M | Buy |
|
|||||
|
2016
Q4 | $316K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $827K | Buy |
|
|||||
|
2015
Q4 | $1.48M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $293K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $958K | Buy |
|